- Report
- October 2024
- 198 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- August 2024
- 71 Pages
Global
From €3500EUR$3,911USD£3,027GBP
- Drug Pipelines
- November 2024
- 60 Pages
Global
From €1198EUR$1,250USD£1,001GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
- Report
- April 2025
- 50 Pages
Global
From €2540EUR$2,650USD£2,123GBP
Biperiden is a centrally acting anticholinergic drug used to treat a variety of conditions related to the central nervous system. It is used to treat Parkinson's disease, dystonia, and drug-induced extrapyramidal reactions. It is also used to treat symptoms of Alzheimer's disease, such as memory loss, confusion, and agitation. Biperiden is also used to treat symptoms of schizophrenia, such as hallucinations, delusions, and disorganized thinking.
Biperiden is available in both oral and injectable forms. It is typically taken orally in the form of tablets or capsules, and is also available as an intramuscular injection. The injectable form is used to treat severe cases of Parkinson's disease and dystonia.
Biperiden is a widely used drug in the central nervous system drug market. It is used to treat a variety of conditions, and is available in both oral and injectable forms.
Some companies in the Biperiden market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more